49,424 Shares in Cognex Corporation $CGNX Acquired by Man Group plc

Key Points

• Man Group acquired 49,424 Cognex shares worth approximately $3.58 million in the second quarter. Institutional investors collectively own 88.12% of Cognex’s outstanding stock.
• Cognex reported quarterly EPS of $0.45, beating estimates by $0.03, while revenue increased 16.9% year over year to $291.26 million. The company guided for fiscal 2026 EPS of $1.64–$1.68.
• Analysts maintain a “Moderate Buy” consensus rating with an average price target of $75.64, compared with the stock’s reported price of $60.96. Cognex also declared a quarterly dividend of $0.085 per share.

Man Group plc bought a new stake in Cognex Corporation (NASDAQ:CGNX - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 49,424 shares of the scientific and technical instruments company's stock, valued at approximately $3,579,000.

A number of other institutional investors also recently added to or reduced their stakes in CGNX. BlackRock Inc. purchased a new stake in shares of Cognex in the 2nd quarter valued at approximately $1,158,123,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of Cognex by 173,138.2% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 10,477,448 shares of the scientific and technical instruments company's stock worth $376,979,000 after purchasing an additional 10,471,400 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Cognex by 31.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,314,896 shares of the scientific and technical instruments company's stock worth $191,231,000 after purchasing an additional 1,258,629 shares during the last quarter. Disciplined Growth Investors Inc. MN grew its stake in shares of Cognex by 0.9% during the second quarter. Disciplined Growth Investors Inc. MN now owns 4,768,716 shares of the scientific and technical instruments company's stock worth $151,264,000 after purchasing an additional 40,927 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Cognex by 27.1% during the fourth quarter. Geode Capital Management LLC now owns 3,950,299 shares of the scientific and technical instruments company's stock worth $142,154,000 after purchasing an additional 842,783 shares in the last quarter. Hedge funds and other institutional investors own 88.12% of the company's stock.

Cognex Price Performance

NASDAQ CGNX opened at $60.96 on Tuesday. The company has a fifty day moving average of $64.30 and a two-hundred day moving average of $59.69. The company has a market capitalization of $10.25 billion, a PE ratio of 59.19 and a beta of 1.49. Cognex Corporation has a 1 year low of $34.60 and a 1 year high of $72.88.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, topping analysts' consensus estimates of $0.42 by $0.03. The business had revenue of $291.26 million for the quarter, compared to analysts' expectations of $292.10 million. Cognex had a return on equity of 13.50% and a net margin of 16.05%.The business's revenue was up 16.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.25 earnings per share. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. On average, research analysts expect that Cognex Corporation will post 1.68 earnings per share for the current year.

Cognex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Thursday, August 20th will be given a dividend of $0.085 per share. The ex-dividend date of this dividend is Thursday, August 20th. This represents a $0.34 annualized dividend and a yield of 0.6%. Cognex's payout ratio is 33.01%.

Analysts Set New Price Targets

A number of research firms have weighed in on CGNX. Barclays restated an "overweight" rating and issued a $80.00 price target (up from $75.00) on shares of Cognex in a research note on Monday, August 10th. Cantor Fitzgerald upped their price objective on Cognex from $76.00 to $84.00 and gave the stock an "overweight" rating in a research report on Friday, August 7th. Citigroup reiterated a "neutral" rating and issued a $74.00 price objective (up from $72.00) on shares of Cognex in a report on Friday, August 7th. Robert W. Baird set a $72.00 target price on Cognex in a research report on Friday, May 8th. Finally, Truist Financial boosted their target price on Cognex from $71.00 to $78.00 and gave the stock a "hold" rating in a research note on Friday, August 7th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Cognex has a consensus rating of "Moderate Buy" and a consensus price target of $75.64.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.